← Back
$KROS All transactions

Keros Therapeutics, Inc.

D

$ Value

$3.4M

Shares

191,527

Price

$18

Filed

Dec 18

Insider

Name

Knowles Julius

Title

CIK

0001808365

Roles

Director

Transaction Details

Transaction Date

2025-11-21

Code

D

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

150,047

Footnotes

Represents shares tendered and accepted for purchase by the Issuer in a cash tender offer commenced by the Issuer on October 20, 2025. The Issuer announced the final results of the tender offer on November 20, 2025. | The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I. | The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.

Filing Info

Accession No.

0001808365-25-000005

Form Type

4

Issuer CIK

0001664710

Knowles Julius's History

Date Ticker Type Value
2025-11-21 KROS D $3.4M
2025-11-21 KROS D $2.3M
2025-06-04 KROS A $0
2025-06-04 KROS A $0

Other Insiders at KROS (90d)

Insider Bought Sold Last
BIENAIME JEAN JACQUES $12K 2026-04-15
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
2026-04-02
Cho Esther
Chief Legal Officer
2026-02-24